Black box warning
Black box warning (also known as a boxed warning or black label warning) is a type of warning that appears on the package insert for certain prescription drugs, as well as on the labeling of the prescription drug itself. The warning is designed to call attention to serious or life-threatening risks that may be associated with the drug.
Overview[edit | edit source]
The Food and Drug Administration (FDA) requires a black box warning for drugs that have specific serious or life-threatening risks. The warning is named for the black border that typically surrounds the text of the warning. The FDA first began requiring black box warnings in 1979.
Purpose[edit | edit source]
The purpose of a black box warning is to alert healthcare professionals and patients to the potential risks associated with a particular drug. The warning is intended to be a clear and concise summary of the most important information about the risks of the drug.
Criteria for a Black Box Warning[edit | edit source]
The FDA may require a black box warning if a drug is associated with serious or life-threatening risks. The decision to require a black box warning is based on a variety of factors, including the severity of the risk, the likelihood of the risk occurring, and the population at risk.
Impact on Prescribing Practices[edit | edit source]
The presence of a black box warning can influence prescribing practices. Some healthcare professionals may choose to prescribe a different drug that does not carry a black box warning, particularly if there are comparable alternatives available. However, in some cases, the benefits of a drug may outweigh the risks, even if the drug carries a black box warning.
Controversies[edit | edit source]
There have been controversies surrounding the use of black box warnings. Some critics argue that the warnings can be overly alarming and may deter patients from taking necessary medications. Others argue that the warnings are not prominent enough and that more should be done to ensure that patients are fully informed of the risks.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
